Back to Spruce Street Capital LP

Spruce Street Capital LP

All holdings · as of Dec 31, 2025

27 positions

CompanyClassValueShares% of portfolio
CIDARA THERAPEUTICS INC$51.31M232,26917.0%
Relay Therapeutics, Inc.$25.25M2,984,1258.3%
LB PHARMACEUTICALS INCLBRXCommon Stock$22.38M1,005,5937.4%
Relmada Therapeutics, Inc.$19.74M4,086,1816.5%
VAXCYTE, INC.$18.47M400,3606.1%
Kiniksa Pharmaceuticals International, plc$17.94M434,9825.9%
EyePoint, Inc.$17.93M981,5435.9%
Savara IncSVRACommon Stock$14.54M2,411,0934.8%
Erasca, Inc.ERASCommon Stock$14.47M3,889,6324.8%
Dianthus Therapeutics, Inc.$12.26M297,4374.0%
Surrozen, Inc./DESRZNCommon Stock$9.76M432,0403.2%
Ocular Therapeutix, Inc$9.52M783,9993.1%
SAB Biotherapeutics, Inc.$8.22M2,198,5022.7%
Inhibikase Therapeutics, Inc.$7.34M3,581,6032.4%
Enliven Therapeutics, Inc.ELVNCommon Stock$6.87M446,0842.3%
MINERVA NEUROSCIENCES, INC.$6.66M1,655,5002.2%
ABIVAX SA$6.62M49,1192.2%
Cybin Inc.$6.30M770,0002.1%
KalVista Pharmaceuticals Inc$6.27M387,9682.1%
ENANTA PHARMACEUTICALS INC$6.15M389,6872.0%
Alto Neuroscience, Inc.ANROCommon Stock$3.97M222,8441.3%
LeonaBio, Inc.LONACommon Stock$2.98M393,7011.0%
CENTESSA PHARMACEUTICALS PLC$1.95M77,9970.6%
Alector, Inc.$1.74M1,117,9860.6%
Lexeo Therapeutics, Inc.$1.74M175,0000.6%
Century Therapeutics, Inc.IPSCCommon Stock$1.41M1,421,5320.5%
Sutro Biopharma, Inc.$874.6K75,5940.3%
← PrevPage 1 of 1Next →